-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cardiovascular disease (CVD), including ischemic heart disease (IHD), ischemic stroke (IS), and hemorrhagic stroke (HS), is the leading cause of the global disease burden
Cardiovascular disease (CVD), including ischemic heart disease (IHD), ischemic stroke (IS), and hemorrhagic stroke (HS), is the leading cause of the global disease burden
The first is to differentiate the risks between IS and HS
Based on the China Kadoorie Biobank (CKB), one of the largest population-based cohorts in the world, researchers have recently established practical disease-specific and overall cardiac outcomes based on widely available variables in Chinese RHR, including IHD, IS, and HS.
The researchers established gender models of ischemic heart disease (IHD), ischemic stroke (IS) and hemorrhagic stroke (HS), and total cardiovascular disease (CVD) in the Chinese Kadoorie Biobank
The researchers established gender models of ischemic heart disease (IHD), ischemic stroke (IS) and hemorrhagic stroke (HS), and total cardiovascular disease (CVD) in the Chinese Kadoorie Biobank
- During the 11-year follow-up period, 489,596 people participated in the model study, including 45,947 IHD, 43,647 IS, and 11,168 HS patients
In addition to excluding blood lipids, this cardiovascular risk prediction model was also able to differentiate between IHD and stroke subtypes well
Classification of evidence: This study provides class I evidence that a predictive model incorporating accessible clinical variables predicts the 10-year risk of ischemic heart disease, ischemic stroke, and hemorrhagic stroke in a Chinese population aged 30-79 years
Source: Yang S, Han Y, Yu C, et al.
Development of Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank [published online ahead of print, 2022 Apr 11].
Neurology.
2022;10.
1212/WNL.
0000000000200139.
doi:10.
1212/WNL.
0000000000200139 Yang S, Han Y, Yu C, et al.
Development of Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank [published online ahead of print, 2022 Apr 11].
Neurology.
2022;10.
1212/WNL.
0000000000200139.
doi:10.
1212/WNL.
0000000000200139Leave
a comment here
